Physician profile
Gilbert Snider
NPI 1588663751
$1,741.05
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $470 · 2020: $377 · 2021: $521 · 2022: $373.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $466.92 | 2019-2022 | |
| Allergan, INC. | $228.96 | 2019-2021 | |
| Amgen INC. | $162.45 | 2019-2022 | |
| Genzyme Corporation | $87.26 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $83.05 | 2020-2022 | |
| Livanova USA, INC. | $79.89 | 2019-2020 | |
| Abbvie INC. | $71.73 | 2021-2022 | |
| Lundbeck LLC | $71.23 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $70.80 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $58.62 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $52.39 | 2021-2022 | |
| Celgene Corporation | $36.27 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $36.13 | 2022 | |
| Ucb, INC. | $32.41 | 2022 | |
| Abbott Laboratories | $23.83 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impel Pharmaceuticals INC. | $22.83 | 2022 | |
| Sk Life Science, INC. | $21.77 | 2021 | |
| Emd Serono, INC. | $19.65 | 2019 | |
| Greenwich Biosciences, INC. | $19.53 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $18.69 | 2021 | |
| Acorda Therapeutics, INC | $18.32 | 2019 | |
| Kyowa Kirin, INC. | $16.30 | 2020 | |
| Jazz Pharmaceuticals INC. | $15.38 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.74 | 2019 | |
| Supernus Pharmaceuticals, INC. | $12.90 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilbert Snider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.